Key word: HT-29, HT29, Growth curve, subcutaneous, Efficacy, immune system humanized, PBMC, T cell, NK, EGFR, 4-1BB, PD-1, 5FU
1、Growth curve
Case 1：
Inoculation method: subcutaneous.
2、Growth curve in systematic PBMC humanized mice model
Case1:
Ino...
煜森资本
煜森资本聚焦国际先进的生物医学科技，旨在打造一流的医疗健康创业和投融资平台。核心团队由一批业内资深企业家、投资人和职业经理人组成，拥有丰富的研发、管理、创业、投资和资本运作经验，并拥有深厚的行业资源
- 关注:0
- 粉丝:184
- 自选:0
- 组合:0
他的全部讨论
新质生产力是撬动医药健康产业创新发展内核最有效的方法论。创模生物科技（北京）有限公司（以下简称：创模生物）成立于2020年，北京市专精特新企业，在双人源化模型领域已有出色表现。初步形成了稳定客户群，正处于高速发展期。近日，《中国企业报》记者围绕医药健康产...
创模生物公司的PBMC-T平台是一项引领生物医学研究的创新技术，旨在提供高效的T细胞产品，为免疫疗法、癌症研究、感染病学等领域的科研人员提供卓越的工具和资源支持。
1. 高效的T细胞生产技术： PBMC-T平台采用先进的细胞培养和扩增技术，确保从人类外周血单个核细胞（Peripheral Blood Mononu...
创模生物公司的PBMC-NK平台是一项创新的生物医学研究技术，专注于提供高质量的自然杀伤细胞（Natural Killer Cells，简称NK细胞）产品，为科研人员在免疫疗法、癌症研究、感染病学等领域提供卓越的工具和资源支持。
1. NK细胞的高效生产技术： PBMC-NK平台采用先进的细胞培养和扩增技术，从人...
InnoModels: Technical characteristics of FACS platform
The FACS (Fluorescence Activated Cell Sorting) platform from InnoModels Biotechnology has revolutionized the field of cellular analysis. With its outstanding features, this advanced platform provides researchers with a comprehensive and efficient solution for cellular analysi...
InnoModels: ELISA Platform Enables Precision Life Science Research
InnoModels Biotechnology has once again launched the ELISA (Enzyme-linked Immunosorbent Assay) platform, an important tool for leading scientific innovation, providing researchers with an efficient, accurate and sensitive tool for life science research.The excellent performan...
InnoModels Biotechnology: Features of the ELISpot Platform
The InnoModels Biotechnology ELISpot platform provides researchers with a highly sensitive and specific method to accurately and rapidly analyze cell-secreted proteins, providing powerful support for research in immunology, oncology and other fields.
Technical features of...
创模生物公司的iHuPBMC-B小鼠模型是一项领先的生物医学研究技术，专注于提供高质量的B淋巴细胞产品，为科研人员在免疫学、感染病学、癌症研究等领域提供卓越的工具和资源支持。
1. B淋巴细胞的高效生产技术： iHuPBMC-B利用先进的细胞培养和扩增技术，从人类外周血单个核细胞（Peripheral Bloo...
创模生物公司再次在生物医学领域展现强大创新力，推出了免疫学研究的创新产品——iHuPBMC-MHC/KO。这一前瞻性的产品为科学家们提供了突破性的工具，助力免疫学研究的深入发展，拓展我们对免疫系统的理解。
iHuPBMC-MHC/KO的技术突破
iHuPBMC-MHC/KO是一种基于人类外周血单个核细胞（Human ...
创模生物公司再次在生物医学领域迈出重要一步，推出了癌症免疫治疗的创新产品——iHuPBMC-OncVax。这一独特的产品标志着公司在癌症治疗领域的技术领先地位，为科学家们提供了更具前瞻性、高效的工具，助力癌症研究与治疗的深入发展。
iHuPBMC-OncVax的技术创新
iHuPBMC-OncVax是一种基于人...
InnoModels Biotechnology: Excellent Features of qPCR Technology
Once again demonstrating its leadership in the field of biotechnology, InnoModels Biotechnology has introduced its highly innovative real-time quantitative Polymerase Chain Reaction (qPCR) technology. This technology not only provides scientists with a more accurate and effic...
InnoModels Biotechnology: Unique Features of Luminex Technology
Pushing the boundaries of technological innovation and leading the way to a new era of multiplexed assays, InnoModels Biotechnology has once again introduced its highly regarded Luminex technology. This technology has emerged as a leader in biomedical research, clinical diagn...
创模生物公司再次在生物医学领域取得巨大突破，推出引领干细胞研究的CD34+ HSC。这一创新的干细胞模型，为科学家们提供了更先进、高效的工具，以深入研究干细胞的生物学特性及其在治疗领域的应用。
CD34+ HSC的技术革新
CD34+ HSC是一种基于CD34标记的造血干细胞（Hematopoietic Stem Cell...
创模生物公司再次突破创新，推出引领免疫研究的PBMC混合接种模型。这一模型的推出不仅标志着公司在生物科技领域的领先地位，更为科学家们提供了一个强大的工具，以更全面、深入地探索免疫系统的各个层面。
PBMC混合接种模型的技术亮点
PBMC混合接种模型是一种基于外周血单个核细胞（Periph...
创模生物公司再次站在科学创新的最前沿，推出了引人注目的PBMC-OncVax肿瘤疫苗模型。这一模型的问世标志着在癌症免疫疗法领域取得了突破，为个性化治疗和疫苗研究带来了崭新的可能性。
PBMC-OncVax模型的核心技术
PBMC-OncVax模型是一种采用患者自身外周血单个核细胞（Peripheral Blood Mo...
InnoModels: Characterization of SCID Mouse NK Efficacy Model
InnoModels Biotechnology has always been committed to promoting cutting-edge biomedical research and providing scientists with advanced research tools and services. Among them, the company's SCID mouse NK efficacy model is an innovation that has attracted much attention i...
创模生物公司一直致力于推动生物医学研究和临床治疗的创新，而旗下的CDX（Cancer-Derived Xenograft）技术成为其在癌症模型领域的引领者。CDX技术的独特性和卓越性能为癌症研究、药物开发和个性化治疗提供了强大的支持。
CDX技术简介
CDX技术是一种基于癌症组织的异种移植技术，通过将患者...
创模生物公司一直致力于推动生物医学领域的创新，而旗下的iHuPDX（Individualized Human Patient-Derived Xenograft）技术正是该公司在个性化医学领域的杰出代表。iHuPDX技术的引入为癌症研究和治疗带来了全新的视角，为医学研究和药物开发提供了更精准、个性化的解决方案。
iHuPDX技术简介
InnoModels: What are the features of the in vivo tumor platform?
The In Vivo Tumor Experimental Platform from InnoModels Biotechnology is an advanced research technology designed to provide a reliable and efficient tool for cancer research and drug development. The following are some of the distinguishing features of the platform:
1. I...
InnoModels: Advantages of Humanized Models of the Immune System
InnoModels's Humanized Model of the Immune System is a remarkable biomedical research technology with many advantages that provide scientists with a powerful tool to advance research in the field of immunology. The following are some of the significant advantages of the m...